Shawn Singh - President and CEO, Director at Vistagen Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
VTGN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Shawn Singh since 10/9/2024

Holdings reported by Shawn Singh for Vistagen Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 20.9K $48.8K $2.34 Jun 30, 2025 By The 1997 Singh Family Trust
Common Stock 18K $30.6K $1.70 Jun 30, 2025 Direct
Stock Option (Right to Buy) 300K Jun 23, 2025 Direct Common Stock

Transactions reported by Shawn Singh for Vistagen Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.